Relationship between Serum Kallistatin and Afamin and Anthropometric Factors Associated with Obesity and of Being Overweight in Patients after Myocardial Infarction and without Myocardial Infarction
Extensive clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular disease (CVD), including coronary disease, heart failure, hypertension, cerebrovascular disease, atrial fibrillation, ventricular arrhythmias, and sudden death. In addition, increasing knowledge...
Main Authors: | Grzegorz Józef Nowicki, Barbara Ślusarska, Maciej Polak, Katarzyna Naylor, Tomasz Kocki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/24/5792 |
Similar Items
-
Serum kallistatin as a marker of severity of liver fibrosis in cirrhosis: A cross-sectional observational study
by: Seetaram Singh Kularaj, et al.
Published: (2022-01-01) -
A Review of Afamin A Metabolic Novel Marker of Many Diseases
by: layla
Published: (2023-12-01) -
Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
by: Yuyu Yao, et al.
Published: (2018-11-01) -
Kallistatin leads to cognition impairment via downregulating glutamine synthetase
by: Yanlan Long, et al.
Published: (2024-04-01) -
Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
by: Zhiyun Cheng, et al.
Published: (2015-05-01)